Search research articles
Contact Us
Filters
Showing results (1-10 of 42) with videos related to
Page
of 5
Sort By:
Frontiers in Oncology
|
March 8, 2021
Sex Differences in Time to Treat and Outcomes for Gliomas
Nickolas Stabellini, Halle Krebs, Nirav Patil, et al.
Cancer Medicine
|
September 28, 2023
Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥26: A National Cancer Database analysis
Nickolas Stabellini, Lifen Cao, Christopher W Towe, et al.
The Journal of Surgical Research
|
January 19, 2023
Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual Disease
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
Cancer
|
April 1, 2022
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis
Lifen Cao, Christopher W Towe, Robert Shenk, et al.
Frontiers in Oncology
|
May 11, 2023
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis
Nickolas Stabellini, Lifen Cao, Christopher W Towe, et al.
Current Problems in Cancer
|
July 10, 2026
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer
Nickolas Stabellini, Maya Lubarsky, Ananya Munjal, et al.
Jornal Vascular Brasileiro
|
May 6, 2022
Temporal trends in vena cava filter implantation in public health system inpatients: an 11-year analysis of the largest city in Brazil
Dafne Braga Diamante Leiderman, Marcelo Fiorelli, Marcelo Passos Teivelis, et al.
Breast Cancer Research and Treatment
|
October 16, 2021
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
Breast Cancer Research and Treatment
|
January 20, 2026
Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study
Nickolas Stabellini, Jasskiran Kaur, Cynthia Owusu, et al.
HIV Medicine
|
September 30, 2023
Heterogeneities of the impact of public health policies on HIV/AIDS indicators in Brazil according to sociodemographic factors: A real-life study
Julie V Sudovec-Somogyi, Felipe Krakauer, Alexandre A Ferreira, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 42) with videos related to
Sort By:
Page
of 5
Frontiers in Oncology
|
March 8, 2021
Sex Differences in Time to Treat and Outcomes for Gliomas
Nickolas Stabellini, Halle Krebs, Nirav Patil, et al.
Cancer Medicine
|
September 28, 2023
Estimating the overall survival benefit of adjuvant chemo-endocrine therapy in women over age 50 with pT1-2N0 early stage breast cancer and 21-gene recurrence score ≥26: A National Cancer Database analysis
Nickolas Stabellini, Lifen Cao, Christopher W Towe, et al.
The Journal of Surgical Research
|
January 19, 2023
Adjuvant Therapy in Breast Cancer Patients With Microscopic Residual Disease
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
Cancer
|
April 1, 2022
A comparison of local therapy alone with local plus systemic therapy for stage I pT1aN0M0 HER2+ breast cancer: A National Cancer Database analysis
Lifen Cao, Christopher W Towe, Robert Shenk, et al.
Frontiers in Oncology
|
May 11, 2023
Adjuvant chemotherapy is associated with an overall survival benefit regardless of age in ER+/HER2- breast cancer pts with 1-3 positive nodes and oncotype DX recurrence score 20 to 25: an NCDB analysis
Nickolas Stabellini, Lifen Cao, Christopher W Towe, et al.
Current Problems in Cancer
|
July 10, 2026
Genomic risk distribution, adjuvant chemotherapy trends, and survival outcomes in women with pT1, grade 1-2, ER/PR-positive, LVI-negative breast cancer
Nickolas Stabellini, Maya Lubarsky, Ananya Munjal, et al.
Jornal Vascular Brasileiro
|
May 6, 2022
Temporal trends in vena cava filter implantation in public health system inpatients: an 11-year analysis of the largest city in Brazil
Dafne Braga Diamante Leiderman, Marcelo Fiorelli, Marcelo Passos Teivelis, et al.
Breast Cancer Research and Treatment
|
October 16, 2021
Adjuvant trastuzumab with or without chemotherapy in stage 1 pT1N0 HER2+ breast cancer: a National Cancer Database analysis
Lifen Cao, Robert Shenk, Nickolas Stabellini, et al.
Breast Cancer Research and Treatment
|
January 20, 2026
Real-world outcomes of reduced-dose versus standard-dose antibody drug conjugates in metastatic breast cancer: a retrospective cohort study
Nickolas Stabellini, Jasskiran Kaur, Cynthia Owusu, et al.
HIV Medicine
|
September 30, 2023
Heterogeneities of the impact of public health policies on HIV/AIDS indicators in Brazil according to sociodemographic factors: A real-life study
Julie V Sudovec-Somogyi, Felipe Krakauer, Alexandre A Ferreira, et al.
Page
of 5